Muller, David A.
Pearson, Frances E.
Fernando, Germain J.P.
Agyei-Yeboah, Christiana
Owens, Nick S.
Corrie, Simon R.
Crichton, Michael L.
Wei, Jonathan C.J.
Weldon, William C.
Oberste, M. Steven
Young, Paul R.
Kendall, Mark A. F.
Article History
Received: 12 November 2015
Accepted: 2 February 2016
First Online: 25 February 2016
Competing interests
: MAFK declares competing financial interests as the founder of Vaxxas and is the inventor on several patents currently licensed by Vaxxas. Vaxxas is a company developing the Nanopatch for drug delivery applications. The remaining authors state no conflict.